Attendees will leave this panel with a deeper understanding of the current hemp and CBD legislation and proposed legislative solutions to current regulatory and legal challenges facing the hemp and hemp-derived cannabinoid industries. Panelists will do a deep dive into current legislative proposals, as well as approaches for the 2023 Farm Bill.
Regulating Cannabinoids: A Comparative Analysis of Intoxicating and Non-Intoxicating Models. The focus of this session is to provide an overview of the Farm Bill and dive into a comparative analysis of regulatory models for intoxicating and non-intoxicating cannabinoids across the country.
In this session the panelists will discuss international hemp-derived products trade. More specifically, the panelists will offer an overview of what transatlantic trade of hemp-derived products (food products, cosmetic products, vaping products…) for consumer use looks like with a particular focus on import and export of these products from the US market to the EU and/or the UK market(s) and from the EU and/or the UK to the USA.
In this session the panelist will set the stage by discussing the Agricultural Improvement Act, more commonly known as the Farm Bill; specifically, the watershed moment in 2018 where industrial hemp was provided a federally legal pathway. The panel will discuss the unintended consequences created by the definition and function of weight allowance for delta-9 THC and its application to manufactured hemp derived products. The impacts of the definition on the hemp industry, the regulated marijuana industry and overall public health.
Learn about the hemp-derived Minnesota Model and how it is viewed as a preview to what will happen on the federal level. As goes Minnesota, so goes the rest of the nation? Join local and national speakers for their analysis and predictions, who will also discuss novel/intoxicating hemp-derived cannabinoids and their regulation under both state and federal law, including Delta-8 THC, THC-O, and others.
The panel will focus on the regulations applicable to foodstuff in the US, Mexico, Colombia and Chile. In particular, we will discuss different regulations in connection to dietary supplements, nutraceuticals, advertisement and further challenging issues for the industry, to later focus on the approach that these regulations have regarding the use of hemp in foodstuff products and future challenges in this regard.
The franchise business model offers hemp business owners the opportunity to grow their brand nationally while reducing their startup and operational costs. It offers prospective hemp franchisees the chance to own their own business while benefiting from an established brand and operational system. But a poorly created franchise system or an “accidental” franchise, can expose hemp businesses to the risk of regulatory investigation, litigation, and the loss of key IP such as trademarks and trade secrets. Conflicting state regulations and the lack of significant federal guidance makes franchising a hemp business even more complex.
Since the 2018 Farm Bill legalized hemp, there are now two distinct commercial industries: pharmaceuticals / wellness and industrial. In the pharmaceutical and consumer wellness areas, there is an explosion of innovation and new products. In the industrial market, there is increasing interest in light of sustainability and carbon capture considerations.
Our distinguished panel of judges will hear argument from both sides—petitioners and the government—and make a decision regarding the legality of marijuana’s continued classification as a Schedule I substance. Come see the exciting hearing unfold!